Ambu A/S traded at 89.55 this Thursday November 5th, increasing 3.60 or 4.19 percent since the previous trading session. Looking back, over the last four weeks, Ambu A/S gained 26.13 percent. Over the last 12 months, its price rose by 7.70 percent. Looking ahead, we forecast Ambu A/S to be priced at 78.17 by the end of this quarter and at 69.75 in one year, according to Trading Economics global macro models projections and analysts expectations.
Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products from resuscitators, face masks and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The Company markets its products worldwide. The Company operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.